BRUSSELS — Belgium has suspended the use of the Johnson & Johnson COVID-19 vaccine for people under age 41 following the death of a person who had received the shot.
The government is asking for urgent advice from the European Medicines Agency before it will consider lifting the suspension.
It said a woman was vaccinated through her foreign employer outside the Belgian system and had died in Belgium last week after developing “serious thrombosis and reduced blood platelets.”
The government says the impact on the national vaccination drive would be very limited. Belgium was using the Johnson & Johnson vaccine for elderly with reduced mobility and the homeless since it only takes one shot to be protected. Those shots will be continued.